COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Reports Second Quarter 2019 Financial Results and Business Updates
09/08/2019
Five patients with MPS IIIB treated in the Transpher B Study of ABO-101 gene therapy Positive interim MPS IIIA data showed preservation of neurocognitive development in youngest patients with robust and sustained [...]
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Fortress Biotech Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Stemline Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]
Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case
09/08/2019
Sandoz to appeal court ruling to United States Court of Appeals for the Federal Circuit Ruling prevents launch of important, affordable treatment option for US patients affected by chronic autoimmune and inflammatory [...]
Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019
09/08/2019
Loughborough, England, Aug. 09, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and [...]
Generex News Alert: Generex to Announce Positive Shareholder News on Monday August 12, 2019 at 8 AM Payment Details for the 1:1 GNBT Stock Dividend
09/08/2019
Dividend to be Paid to show Appreciation to our Shareholders MIRAMAR, Fla., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) (“Generex”) today provided a news alert [...]
CORRECTION: PROJECT HOPE CALLS FOR CONTINUED FOREIGN AID AMIDST GLOBAL CRISES THREATENING LIVES AND LIVELIHOODS
09/08/2019
90 humanitarian and development organizations urge the U.S. administration to reconsider freezing funds for U.S. foreign assistance programs Millwood, Virginia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- The global health and [...]
Wellness Matrix Addresses OTC Caveat Emptor Issue
09/08/2019
HUNTINGTON BEACH, Calif. , Aug. 09, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix (OTC PINK: WMGR) today announced that the company's status of its Caveat Emptor label is being addressed. Wellness Matrix understands that [...]
BioHemp International, Inc. (OTC: BKIT) Acts in Response to SEC and OTC Trading Suspension
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – As previously disclosed on July 26th, 2019, the Securities and Exchange Commission ("Commission") announced the temporary suspension, pursuant to Section 12( [...]
TR-1: Standard form for notification of major holdings
09/08/2019
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are [...]
Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021
09/08/2019
LAKE FOREST, Ill., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange [...]
NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock
09/08/2019
EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today [...]
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
09/08/2019
EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today [...]
Predictive Technology Group Announces Launch of PGxPLUS+™ Pharmacogenomic Test and Reaches Clinical Study Enrollment Milestone
09/08/2019
Enrollment reaches 350 patients for IRB-approved study focused on chronic pain SALT LAKE CITY, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics [...]
PROJECT HOPE CALLS FOR CONTINUED FOREIGN AID AMIDST GLOBAL CRISES THREATENING LIVES AND LIVELIHOODS
09/08/2019
90 humanitarian and development organizations urge the U.S. administration to reconsider freezing funds for U.S. foreign assistance programs Millwood, Virginia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- “Millions of children, [...]
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
09/08/2019
Reports Positive Preliminary Top-Line Safety Data for APVO210 Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Commences Dosing in Cohort 4 of APVO436 [...]
B. Braun Awarded Best Research Article of 2018 by BI&T
09/08/2019
First-of-its-kind Study Reveals Impact of Infusion Pump Alarms on Patients and Clinicians BETHLEHEM, Pa., Aug. 09, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced that it has been selected by the Association [...]
Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
09/08/2019
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule [...]

Pages